Dietary emulsifier consumption accelerates type 1 diabetes development in NOD mice

被引:0
|
作者
Clara Delaroque
Benoit Chassaing
机构
[1] Université Paris Cité,INSERM U1016, team “Mucosal microbiota in chronic inflammatory diseases”, CNRS UMR 8104
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The rapidly increasing prevalence of type 1 diabetes (T1D) underscores the role of environmental (i.e. non-genetic) determinants of T1D development. Such factors include industrialized diets as well as the intestinal microbiota with which they interact. One component of industrialized diets that deleteriously impact gut microbiota is dietary emulsifiers, which perturb intestinal microbiota to encroach upon their host promoting chronic low-grade intestinal inflammation and metabolic syndrome. Hence, we investigated whether 2 dietary emulsifiers, carboxymethylcellulose (CMC) and polysorbate-80 (P80), might influence the development of T1D in NOD mice, which spontaneously develop this disorder. We observed that chronic emulsifier exposure accelerated T1D development in NOD mice, which was associated with increased insulin autoantibody levels. Such accelerated T1D development was accompanied by compositional and functional alterations of the intestinal microbiota as well as low-grade intestinal inflammation. Moreover, machine learning found that the severity of emulsifier-induced microbiota disruption had partial power to predict subsequent disease development, suggesting that complex interactions occur between the host, dietary factors, and the intestinal microbiota. Thus, perturbation of host–microbiota homeostasis by dietary emulsifiers may have contributed to the post-mid-20th-century increase in T1D.
引用
收藏
相关论文
共 50 条
  • [31] MyD88 mediated environmental effect on type 1 diabetes development in NOD mice
    Chervonsky, A.
    Hu, C. Y.
    Du, W.
    Lu, B.
    Zhang, L.
    Wong, S. F.
    Wen, L.
    ACTA DIABETOLOGICA, 2007, 44 : S54 - S54
  • [32] Interferon-γ receptor signaling is dispensable in the development of autoimmune type 1 diabetes in NOD mice
    Serreze, DV
    Post, CM
    Chapman, HD
    Johnson, EA
    Lu, BF
    Rothman, PB
    DIABETES, 2000, 49 (12) : 2007 - 2011
  • [33] Antibiotic-mediated gut microbiome perturbation accelerates development of type 1 diabetes in mice
    Livanos, Alexandra E.
    Greiner, Thomas U.
    Vangay, Pajau
    Pathmasiri, Wimal
    Stewart, Delisha
    McRitchie, Susan
    Li, Huilin
    Chung, Jennifer
    Sohn, Jiho
    Kim, Sara
    Gao, Zhan
    Barber, Cecily
    Kim, Joanne
    Ng, Sandy
    Rogers, Arlin B.
    Sumner, Susan
    Zhang, Xue-Song
    Cadwell, Ken
    Knights, Dan
    Alekseyenko, Alexander
    Backhed, Fredrik
    Blaser, Martin J.
    NATURE MICROBIOLOGY, 2016, 1 (11):
  • [34] Antibiotic-mediated gut microbiome perturbation accelerates development of type 1 diabetes in mice
    Livanos A.E.
    Greiner T.U.
    Vangay P.
    Pathmasiri W.
    Stewart D.
    McRitchie S.
    Li H.
    Chung J.
    Sohn J.
    Kim S.
    Gao Z.
    Barber C.
    Kim J.
    Ng S.
    Rogers A.B.
    Sumner S.
    Zhang X.-S.
    Cadwell K.
    Knights D.
    Alekseyenko A.
    B'ckhed F.
    Blaser M.J.
    Nature Microbiology, 1 (11)
  • [35] DIMETHYL-SULFOXIDE MARKEDLY ACCELERATES DIABETES ONSET IN NOD MICE
    KLANDORF, H
    CHIRRA, AR
    GIRMAN, DJ
    MULLEN, Y
    CLINICAL RESEARCH, 1988, 36 (01): : A155 - A155
  • [36] Diabetes accelerates atherosclerosis in non-obese diabetic (NOD) mice
    Kirk, EA
    LeBoeuf, RC
    CIRCULATION, 1996, 94 (08) : 206 - 206
  • [37] A Nod to type 1 diabetes
    Zoltan Fehervari
    Nature Immunology, 2016, 17 (8) : 905 - 905
  • [38] Long-term bisphenol A exposure accelerates insulitis development in diabetes-prone NOD mice
    Bodin, Johanna
    Bolling, Anette Kocbach
    Samuelsen, Mari
    Becher, Rune
    Lovik, Martinus
    Nygaard, Unni Cecilie
    IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2013, 35 (03) : 349 - 358
  • [39] An update on the use of NOD mice to study autoimmune (Type 1) diabetes
    Chaparro, Rodolfo Jose
    DiLorenzo, Teresa P.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2010, 6 (06) : 939 - 955
  • [40] Basal insulin analogs for the prevention of type 1 diabetes in NOD mice
    Karounos, DG
    DIABETES, 2005, 54 : A314 - A314